Skip to main content
. 2016 Jan 12;7(7):8029–8042. doi: 10.18632/oncotarget.6904

Figure 3. Knockdown of ZYG11A retards tumor growth in vivo.

Figure 3

a. Tumor nodules from mice injected with sh-ZYG11A cells are significantly smaller than those injected with NC cells. b. sh-ZYG11A tumors from both H1299 and SPC-A-1 cell lines have less dense PCNA staining. c. Compared with the NC group, the sh-ZYG11A group has reduced tumor size. d. Both mRNA and protein expression of CCNE1 are decreased in the sh-ZYG11A group compared with NC group, and ZYG11A expression is also decreased.